Article Information
PubMed
Published By
History
- Received May 20, 2021
- Revision received July 26, 2021
- Accepted August 3, 2021
- Published online September 2, 2021.
Copyright & Usage
Copyright © 2021 Pensieri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Pasquale Pensieri1,*,
- Annabelle Mantilleri1,*,
- Damien Plassard2,
- Takahisa Furukawa3,
- Kenneth L. Moya4,
- Alain Prochiantz4 and
- Thomas Lamonerie1
- 1Université Côte d’Azur, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institut de Biologie Valrose, Nice 06108, France
- 2Plateforme GenomEast, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch 67404, France
- 3Laboratory for Molecular and Developmental Biology, Institute for Protein Research, Osaka University, Osaka 565-0871, Japan
- 4Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7241, Institut National de la Santé et de la Recherche Médicale Unité 1050, Paris 75005, France
- Correspondence should be addressed to Thomas Lamonerie at thomas.lamonerie{at}univ-cotedazur.fr.
Author contributions
Author contributions: K.L.M., A.P., and T.L. designed research; P.P., A.M., and D.P. performed research; T.F. contributed unpublished reagents/analytic tools; P.P., A.M., D.P., T.F., K.L.M., A.P., and T.L. analyzed data; T.L. wrote the paper.
↵* P.P. and A.M. contributed equally to this work.
Disclosures
K.L.M. and A.P. are listed on patents for the use of homeoproteins to treat neurodegenerative disease, and each holds equity in a startup company with that aim. All other authors declare no competing financial interests.
This work was supported by the Agence Nationale de la Recherche Grant ANR-16-CE16-0003-NeuroprOtx.
Funding
Agence Nationale de la Recherche (ANR)
ANR-16-CE16-0003-NeuroprOtx
Other Version
- You are viewing the most recent version of this article.
- previous version (September 02, 2021).
Article usage
In this issue
Photoreceptor cKO of OTX2 Enhances OTX2 Intercellular Transfer in the Retina and Causes Photophobia
